1/16/2013

Melanoma cells treated with vemurafenib eventually use the drug to fuel growth of rapidly progressing drug-resistant tumors, a study in mice found. Dosing intermittently may prevent the growth of drug-resistant tumors, researchers said.

Full Story:
Dermatology Times

Related Summaries